,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Constipation,2,16904954
1,22.1,Epistaxis,2,16904954
2,22.1,Lymphoedema,2,16904954
3,22.1,Neutrophil count decreased,2,16904954
4,22.1,Condition aggravated,2,16904954
5,22.1,Pyrexia,2,16904954
0,22.1,Platelet count decreased,1,16904959
0,22.1,Atrioventricular block complete,1,16904993
1,22.1,Hypothyroidism,3,16904993
0,22.1,Neutropenia,,16905053
0,22.1,Death,,16905068
0,22.1,Lupus-like syndrome,1,16905074
1,22.1,Mouth ulceration,6,16905074
0,22.1,Bronchitis,,16905088
1,22.1,Urinary tract infection,,16905088
0,22.1,Breast cancer,6,16905091
1,22.1,Transaminases abnormal,6,16905091
2,22.1,Metastases to lung,6,16905091
3,22.1,Metastases to lymph nodes,6,16905091
4,22.1,Neurotoxicity,6,16905091
5,22.1,Metastases to liver,6,16905091
6,22.1,Anaemia,6,16905091
7,22.1,Wrong technique in product usage process,6,16905091
8,22.1,Malignant neoplasm progression,6,16905091
9,22.1,Metastases to bone,6,16905091
0,22.1,Metastases to lymph nodes,6,16905093
1,22.1,Metastases to central nervous system,6,16905093
2,22.1,Metastases to thyroid,6,16905093
3,22.1,Malignant neoplasm progression,3,16905093
0,22.1,Blood pressure increased,,16905105
0,22.1,Alopecia,3,16905134
1,22.1,Hair disorder,3,16905134
2,22.1,Anxiety,3,16905134
3,22.1,Hair texture abnormal,3,16905134
4,22.1,Hair colour changes,3,16905134
0,22.1,Haemoglobin decreased,6,16905140
1,22.1,Muscular weakness,6,16905140
2,22.1,Platelet count decreased,6,16905140
3,22.1,Decreased appetite,6,16905140
0,22.1,Salivary hypersecretion,3,16905141
1,22.1,Muscle spasms,1,16905141
2,22.1,Rhinorrhoea,3,16905141
3,22.1,Rhinitis allergic,3,16905141
4,22.1,Herpes simplex,6,16905141
5,22.1,Oral pain,1,16905141
6,22.1,Upper-airway cough syndrome,3,16905141
7,22.1,Condition aggravated,3,16905141
0,22.1,Orthostatic hypotension,3,16905146
1,22.1,Aspartate aminotransferase increased,6,16905146
2,22.1,Syncope,3,16905146
3,22.1,Dizziness postural,3,16905146
4,22.1,Neoplasm progression,5,16905146
0,22.1,Blood count abnormal,1,16905148
0,22.1,Stomatitis,2,16905151
0,22.1,Fall,6,16905154
1,22.1,Osteoporosis,6,16905154
2,22.1,Malaise,6,16905154
3,22.1,Second primary malignancy,6,16905154
4,22.1,Neuroendocrine carcinoma,6,16905154
5,22.1,Contusion,6,16905154
6,22.1,Product dose omission,6,16905154
0,22.1,Neoplasm progression,6,16905155
0,22.1,Arthropathy,3,16905168
1,22.1,Decubitus ulcer,3,16905168
2,22.1,Bone disorder,3,16905168
3,22.1,Neoplasm progression,3,16905168
0,22.1,Product prescribing error,6,16905270
1,22.1,Product storage error,6,16905270
0,22.1,Atypical femur fracture,6,16905466
1,22.1,Product use issue,6,16905466
2,22.1,Stress fracture,6,16905466
0,22.1,Thrombosis,6,16905469
1,22.1,Fall,6,16905469
0,22.1,Febrile neutropenia,1,16905473
0,22.1,Humerus fracture,3,16905489
1,22.1,Cerebrovascular accident,3,16905489
0,22.1,Hormone-refractory prostate cancer,5,16905505
0,22.1,Supraventricular tachycardia,6,16905571
1,22.1,Malaise,3,16905571
2,22.1,Peripheral swelling,6,16905571
3,22.1,Dyspnoea,6,16905571
4,22.1,Decreased appetite,6,16905571
5,22.1,Product physical issue,6,16905571
6,22.1,Feeling abnormal,6,16905571
7,22.1,Asthenia,6,16905571
8,22.1,Hypertension,3,16905571
9,22.1,Neutrophil count decreased,6,16905571
10,22.1,Basal cell carcinoma,1,16905571
11,22.1,Hiccups,1,16905571
12,22.1,Loss of personal independence in daily activities,6,16905571
13,22.1,Fatigue,3,16905571
14,22.1,Red blood cell count decreased,3,16905571
15,22.1,Product dose omission,6,16905571
16,22.1,Oropharyngeal pain,6,16905571
17,22.1,Memory impairment,3,16905571
18,22.1,Temperature regulation disorder,6,16905571
19,22.1,Blood count abnormal,6,16905571
20,22.1,Alopecia,6,16905571
21,22.1,Granulocyte count decreased,3,16905571
22,22.1,Blood cholesterol increased,3,16905571
23,22.1,Laboratory test abnormal,6,16905571
24,22.1,Flatulence,6,16905571
25,22.1,Nausea,6,16905571
26,22.1,Dizziness,6,16905571
27,22.1,Skin discolouration,6,16905571
28,22.1,Hot flush,6,16905571
29,22.1,Pruritus,3,16905571
30,22.1,Urine odour abnormal,6,16905571
31,22.1,Insomnia,3,16905571
32,22.1,Platelet count decreased,3,16905571
33,22.1,Productive cough,3,16905571
34,22.1,Product dispensing error,6,16905571
35,22.1,Musculoskeletal pain,6,16905571
36,22.1,Erythema,6,16905571
37,22.1,Mean platelet volume decreased,3,16905571
38,22.1,Headache,3,16905571
39,22.1,White blood cell count decreased,3,16905571
40,22.1,Palpitations,1,16905571
0,22.1,Diarrhoea,6,16905572
1,22.1,Constipation,6,16905572
2,22.1,Aneurysm,6,16905572
0,22.1,Prostate cancer,5,16905609
0,22.1,No adverse event,6,16905614
0,22.1,Prostate cancer,5,16905621
0,22.1,Headache,6,16905639
1,22.1,Toothache,6,16905639
2,22.1,Death,5,16905639
3,22.1,Neoplasm progression,6,16905639
4,22.1,Tooth disorder,6,16905639
5,22.1,Pain,3,16905639
6,22.1,Speech disorder,3,16905639
7,22.1,Malaise,3,16905639
8,22.1,Eating disorder,6,16905639
0,22.1,Febrile neutropenia,6,16905665
1,22.1,Malignant neoplasm progression,5,16905665
0,22.1,Product use in unapproved indication,6,16905726
1,22.1,Mental disorder,1,16905726
2,22.1,Personality change,6,16905726
3,22.1,Confusional state,1,16905726
0,22.1,Vascular pseudoaneurysm,1,16905737
1,22.1,Treatment failure,6,16905737
0,22.1,Adrenocorticotropic hormone deficiency,1,16905738
1,22.1,Pruritus,6,16905738
0,22.1,Nausea,6,16905752
1,22.1,Dyspnoea,6,16905752
2,22.1,Gastrointestinal disorder,6,16905752
3,22.1,Rash,6,16905752
4,22.1,Atelectasis,6,16905752
5,22.1,Computerised tomogram thorax abnormal,6,16905752
6,22.1,Pyrexia,6,16905752
7,22.1,Cough,6,16905752
8,22.1,Fatigue,6,16905752
9,22.1,Hypoxia,6,16905752
10,22.1,Off label use,6,16905752
0,22.1,Death,5,16905758
0,22.1,Death,5,16905759
0,22.1,Cerebrovascular accident,6,16905760
1,22.1,Hypercoagulation,6,16905760
0,22.1,Death,5,16905761
1,22.1,Off label use,6,16905761
0,22.1,Death,5,16905762
0,22.1,Haemoglobin decreased,3,16905801
1,22.1,Nasopharyngitis,3,16905801
2,22.1,Urticaria,3,16905801
3,22.1,White blood cell count increased,3,16905801
4,22.1,Monocyte count decreased,3,16905801
5,22.1,Pharyngeal oedema,3,16905801
6,22.1,Throat tightness,3,16905801
7,22.1,Alanine aminotransferase increased,3,16905801
8,22.1,Condition aggravated,3,16905801
9,22.1,Neutrophil count increased,3,16905801
10,22.1,Tachycardia,3,16905801
11,22.1,Throat irritation,3,16905801
12,22.1,Back pain,3,16905801
13,22.1,Cholecystitis,3,16905801
14,22.1,Eye swelling,3,16905801
15,22.1,Flank pain,3,16905801
16,22.1,Lip swelling,3,16905801
17,22.1,Red blood cell count decreased,3,16905801
18,22.1,Pyrexia,3,16905801
19,22.1,Eye pain,3,16905801
20,22.1,Headache,3,16905801
21,22.1,Lymphocyte count decreased,3,16905801
22,22.1,Abdominal pain upper,3,16905801
23,22.1,Aspartate aminotransferase increased,3,16905801
24,22.1,Haematocrit decreased,3,16905801
25,22.1,Leukopenia,3,16905801
0,22.1,Hypertensive heart disease,3,16905887
1,22.1,Urticaria,3,16905887
2,22.1,Infusion related reaction,3,16905887
0,22.1,Septic shock,5,16905893
0,22.1,Malignant neoplasm progression,6,16905898
1,22.1,Drug resistance,6,16905898
2,22.1,Drug ineffective,6,16905898
0,22.1,Hyperpyrexia,1,16905936
0,22.1,Cholestasis,5,16906030
0,22.1,Anaemia,1,16906035
1,22.1,Diarrhoea,1,16906035
2,22.1,Leukopenia,3,16906035
3,22.1,Neutropenia,1,16906035
4,22.1,Fatigue,3,16906035
5,22.1,Bone pain,3,16906035
0,22.1,Ulcer,2,16906049
1,22.1,Chest pain,2,16906049
2,22.1,Haematemesis,1,16906049
3,22.1,Stoma site haemorrhage,1,16906049
0,22.1,Corneal endotheliitis,1,16906144
1,22.1,Conjunctivitis,1,16906144
2,22.1,Herpes ophthalmic,1,16906144
3,22.1,Episcleritis,1,16906144
4,22.1,Cataract,6,16906144
5,22.1,Conjunctivitis,1,16906144
0,22.1,Death,5,16906192
0,22.1,Neutropenia,6,16906204
0,22.1,Dry eye,2,16906258
1,22.1,Ulcerative keratitis,2,16906258
0,22.1,Eosinophilic granulomatosis with polyangiitis,1,16906263
0,22.1,Decreased appetite,3,16906296
0,22.1,Dyspnoea,6,16906309
1,22.1,Eosinophil count increased,6,16906309
2,22.1,Hypersensitivity,6,16906309
3,22.1,Acute respiratory distress syndrome,6,16906309
4,22.1,Chest discomfort,6,16906309
0,22.1,Neuropathy peripheral,3,16906312
0,22.1,Diarrhoea,5,16906362
1,22.1,Neutropenia,5,16906362
2,22.1,Pyrexia,5,16906362
3,22.1,Palmar-plantar erythrodysaesthesia syndrome,5,16906362
4,22.1,Vomiting,5,16906362
5,22.1,Megacolon,5,16906362
6,22.1,Dehydration,5,16906362
7,22.1,Thrombocytopenia,5,16906362
8,22.1,Sepsis,5,16906362
0,22.1,Interstitial lung disease,1,16906387
0,22.1,Large intestine polyp,6,16906389
0,22.1,Dehydration,6,16906402
1,22.1,Diarrhoea,6,16906402
2,22.1,Mycotic endophthalmitis,6,16906402
0,22.1,Anxiety,6,16906407
1,22.1,Small intestinal obstruction,6,16906407
0,22.1,General physical health deterioration,6,16906475
0,22.1,Bone marrow failure,6,16906481
1,22.1,Putamen haemorrhage,4,16906481
0,22.1,Lung disorder,1,16906508
0,22.1,Type I hypersensitivity,1,16906537
1,22.1,Off label use,6,16906537
0,22.1,Diarrhoea,6,16906589
1,22.1,Blood creatinine increased,6,16906589
2,22.1,Drug intolerance,6,16906589
3,22.1,Toxicity to various agents,6,16906589
0,22.1,Squamous cell carcinoma,6,16906624
0,22.1,Malignant neoplasm progression,3,16906706
0,22.1,Fatigue,3,16906723
1,22.1,Nausea,3,16906723
2,22.1,Burning sensation,3,16906723
3,22.1,Weight decreased,3,16906723
4,22.1,Infusion related reaction,3,16906723
5,22.1,Blood pressure systolic increased,3,16906723
6,22.1,Hyperchlorhydria,3,16906723
7,22.1,Blood pressure inadequately controlled,3,16906723
8,22.1,Diarrhoea,3,16906723
0,22.1,Intestinal perforation,1,16906731
0,22.1,Chest pain,1,16906732
1,22.1,Neutropenia,1,16906732
2,22.1,Neutropenia,1,16906732
3,22.1,Alanine aminotransferase increased,1,16906732
4,22.1,Alanine aminotransferase increased,1,16906732
5,22.1,Mucosal dryness,6,16906732
6,22.1,Alanine aminotransferase increased,1,16906732
0,22.1,Pyelonephritis,1,16906736
0,22.1,Cardiac failure,4,16906757
1,22.1,Embolism,4,16906757
0,22.1,Urinary tract infection,2,16906780
1,22.1,Embolism,2,16906780
0,22.1,Immune thrombocytopenic purpura,2,16906788
0,22.1,Hepatocellular injury,1,16906805
0,22.1,Alveolitis,5,16906810
1,22.1,Atrial fibrillation,5,16906810
2,22.1,Hypoxia,5,16906810
0,22.1,Haemoptysis,1,16906811
1,22.1,Pulmonary embolism,1,16906811
0,22.1,Interstitial lung disease,5,16906818
0,22.1,Cholestasis,5,16906820
0,22.1,Urticaria,1,16906832
1,22.1,Infusion related reaction,3,16906832
2,22.1,Hypertensive heart disease,3,16906832
0,22.1,Thrombocytopenia,6,16906849
1,22.1,Alopecia,6,16906849
2,22.1,Leukopenia,6,16906849
3,22.1,Intentional product use issue,6,16906849
4,22.1,Anaemia,6,16906849
5,22.1,Off label use,6,16906849
6,22.1,Diarrhoea,6,16906849
7,22.1,Hepatotoxicity,6,16906849
8,22.1,Vomiting,6,16906849
9,22.1,Cardiotoxicity,6,16906849
10,22.1,Nausea,6,16906849
0,22.1,Platelet count decreased,6,16906863
0,22.1,Macroenzyme creatine kinase,6,16906870
1,22.1,False positive investigation result,6,16906870
0,22.1,Pneumonia aspiration,2,16906894
0,22.1,Malignant neoplasm progression,6,16906908
1,22.1,Anaemia,6,16906908
0,22.1,Platelet count decreased,6,16906973
1,22.1,Nausea,6,16906973
2,22.1,White blood cell count decreased,6,16906973
3,22.1,Anaemia,6,16906973
4,22.1,Malignant neoplasm progression,6,16906973
0,22.1,Oedema,1,16906977
1,22.1,Transaminases increased,1,16906977
0,22.1,Immune thrombocytopenic purpura,2,16906988
0,22.1,Anxiety,1,16907034
1,22.1,Dyspnoea,1,16907034
2,22.1,Chills,1,16907034
3,22.1,Vomiting,1,16907034
4,22.1,Off label use,6,16907034
0,22.1,Melaena,1,16907035
0,22.1,Infection,6,16907066
1,22.1,Blood potassium abnormal,6,16907066
2,22.1,Balance disorder,6,16907066
3,22.1,Underdose,6,16907066
4,22.1,Hypertension,6,16907066
5,22.1,Product dose omission,6,16907066
6,22.1,Bladder disorder,6,16907066
0,22.1,Death,5,16907088
0,22.1,Neutropenia,6,16907089
1,22.1,Diarrhoea,6,16907089
2,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,16907089
3,22.1,Skin reaction,6,16907089
0,22.1,Haematemesis,1,16907152
1,22.1,Stoma site haemorrhage,1,16907152
2,22.1,Chest pain,2,16907152
3,22.1,Ulcer,2,16907152
0,22.1,Febrile bone marrow aplasia,2,16907173
0,22.1,Drug ineffective,6,16907178
1,22.1,Cognitive disorder,6,16907178
0,22.1,Cerebral venous thrombosis,3,16907237
0,22.1,General physical health deterioration,6,16907304
1,22.1,Cough,6,16907304
2,22.1,Metastasis,6,16907304
0,22.1,Rash,6,16907353
0,22.1,Decreased appetite,2,16907380
1,22.1,Delirium,3,16907380
2,22.1,Oedema,2,16907380
3,22.1,Constipation,2,16907380
4,22.1,Lung disorder,2,16907380
0,22.1,Extravasation,2,16907391
0,22.1,Hepatic enzyme increased,6,16907446
0,22.1,Febrile bone marrow aplasia,2,16907448
0,22.1,Hypersensitivity vasculitis,6,16907490
1,22.1,Headache,6,16907490
2,22.1,Hyperhidrosis,6,16907490
3,22.1,Arthralgia,6,16907490
0,22.1,Fatigue,6,16907504
1,22.1,Musculoskeletal discomfort,6,16907504
2,22.1,Joint stiffness,6,16907504
3,22.1,Androgenetic alopecia,6,16907504
4,22.1,Constipation,6,16907504
5,22.1,Lymphocytosis,6,16907504
6,22.1,Mucosal dryness,6,16907504
7,22.1,Neutropenia,6,16907504
0,22.1,Troponin increased,4,16907586
0,22.1,Leukopenia,2,16907588
0,22.1,No adverse event,6,16907592
0,22.1,Pneumonia,5,16907699
0,22.1,Pneumonia,6,16907736
1,22.1,Encephalopathy,6,16907736
0,22.1,Lung disorder,1,16907746
0,22.1,Gout,3,16907785
0,22.1,Nephrotic syndrome,6,16907829
1,22.1,Oedema peripheral,6,16907829
2,22.1,Proteinuria,6,16907829
3,22.1,Vascular device infection,6,16907829
4,22.1,Post infection glomerulonephritis,6,16907829
0,22.1,Anaemia,6,16907832
1,22.1,Wrong technique in product usage process,6,16907832
2,22.1,Transaminases abnormal,6,16907832
3,22.1,Neurotoxicity,6,16907832
4,22.1,Malignant neoplasm progression,6,16907832
0,22.1,Pain,6,16907834
1,22.1,Nausea,1,16907834
2,22.1,Chest pain,2,16907834
3,22.1,Constipation,1,16907834
4,22.1,Vomiting,1,16907834
5,22.1,Leukopenia,1,16907834
0,22.1,Hypoxia,5,16907853
1,22.1,Condition aggravated,5,16907853
2,22.1,Interstitial lung disease,5,16907853
0,22.1,Aortic stenosis,3,16907871
1,22.1,Cardiac failure,3,16907871
2,22.1,Drug interaction,3,16907871
3,22.1,Mitral valve incompetence,3,16907871
4,22.1,Ischaemic cardiomyopathy,3,16907871
0,22.1,Syncope,6,16907966
1,22.1,Sepsis,6,16907966
2,22.1,Fall,6,16907966
0,22.1,Eye irritation,3,16907971
1,22.1,Diarrhoea,3,16907971
2,22.1,Vision blurred,3,16907971
3,22.1,Neuropathy peripheral,3,16907971
4,22.1,Off label use,,16907971
5,22.1,Dysphonia,3,16907971
6,22.1,Fatigue,3,16907971
7,22.1,Nausea,3,16907971
0,22.1,Hormone-refractory prostate cancer,,16907978
1,22.1,Metastases to lymph nodes,,16907978
0,22.1,Neuropathy peripheral,3,16908036
1,22.1,Balance disorder,3,16908036
2,22.1,Gastrointestinal motility disorder,3,16908036
0,22.1,Neuropathy peripheral,6,16908095
1,22.1,Hypertension,6,16908095
0,22.1,Fall,6,16908123
1,22.1,Spinal cord disorder,2,16908123
2,22.1,Gastrooesophageal reflux disease,2,16908123
0,22.1,Death,5,16908178
0,22.1,Pneumonia,5,16908184
0,22.1,Dizziness,,16908186
1,22.1,Blood glucose decreased,,16908186
2,22.1,Incoherent,,16908186
0,22.1,Asthenia,,16908191
1,22.1,Dehydration,,16908191
2,22.1,Decreased appetite,,16908191
3,22.1,Dizziness,,16908191
0,22.1,Burning sensation,1,16908199
1,22.1,Neoplasm progression,6,16908199
2,22.1,Gastrointestinal haemorrhage,1,16908199
3,22.1,Epistaxis,1,16908199
4,22.1,Erythema,1,16908199
5,22.1,Weight increased,6,16908199
0,22.1,Vasculitis,5,16908253
1,22.1,Neutropenia,5,16908253
2,22.1,Off label use,6,16908253
3,22.1,Renal failure,5,16908253
0,22.1,Hepatotoxicity,6,16908256
0,22.1,Dizziness,6,16908269
1,22.1,Blood glucose decreased,6,16908269
0,22.1,Prostate cancer,2,16908275
1,22.1,Drug interaction,2,16908275
2,22.1,Drug level decreased,2,16908275
3,22.1,Drug ineffective,2,16908275
0,22.1,Bone pain,3,16908296
1,22.1,Death,5,16908296
2,22.1,Dehydration,3,16908296
3,22.1,Pain in jaw,3,16908296
4,22.1,Malaise,3,16908296
0,22.1,Conjunctivitis,3,16908309
1,22.1,Keratitis,3,16908309
0,22.1,Stevens-Johnson syndrome,2,16908314
1,22.1,Erythema,6,16908314
0,22.1,Pneumonia,5,16908323
0,22.1,Lower limb fracture,3,16908337
1,22.1,Fall,6,16908337
2,22.1,Hip fracture,3,16908337
3,22.1,Pruritus,3,16908337
0,22.1,Death,5,16908389
0,22.1,Metastases to bone,6,16908413
1,22.1,Myositis,2,16908413
0,22.1,Hepatic failure,1,16908468
0,22.1,Cholestasis,5,16908478
0,22.1,Intestinal perforation,1,16908486
0,22.1,Asthenia,6,16908522
1,22.1,Swelling,6,16908522
2,22.1,Sinus disorder,6,16908522
3,22.1,Staphylococcal infection,6,16908522
4,22.1,Chest pain,6,16908522
5,22.1,Pain,6,16908522
6,22.1,Palpitations,6,16908522
7,22.1,Pain in extremity,6,16908522
8,22.1,Skin discolouration,6,16908522
9,22.1,Joint swelling,6,16908522
0,22.1,Disease progression,,16908529
0,22.1,Bone cancer metastatic,6,16908564
0,22.1,Neurotoxicity,6,16908571
1,22.1,Anaemia,6,16908571
2,22.1,Second primary malignancy,6,16908571
3,22.1,Metastases to lung,6,16908571
4,22.1,Wrong technique in product usage process,6,16908571
5,22.1,Transaminases abnormal,6,16908571
6,22.1,Neoplasm progression,6,16908571
0,22.1,Death,5,16908587
0,22.1,White blood cell count decreased,2,16908598
1,22.1,Asthenia,2,16908598
0,22.1,Fall,6,16908600
1,22.1,Drug hypersensitivity,6,16908600
2,22.1,Lacrimation increased,6,16908600
3,22.1,Haemorrhage,6,16908600
4,22.1,Eye allergy,6,16908600
5,22.1,Amnesia,6,16908600
6,22.1,Foreign body sensation in eyes,6,16908600
7,22.1,Injury,6,16908600
8,22.1,Dyspnoea,6,16908600
0,22.1,Death,5,16908622
0,22.1,Hepatic failure,5,16908631
0,22.1,Bone marrow disorder,,16908632
1,22.1,Prostatic specific antigen increased,,16908632
0,22.1,Death,5,16908660
0,22.1,Death,5,16908708
0,22.1,Pain,6,16908714
1,22.1,White blood cell count decreased,6,16908714
2,22.1,Cough,1,16908714
0,22.1,Citrobacter infection,6,16908717
1,22.1,Constipation,1,16908717
2,22.1,Chest pain,1,16908717
3,22.1,Cholelithiasis,6,16908717
0,22.1,Death,5,16908730
0,22.1,Memory impairment,6,16908747
1,22.1,Depression,6,16908747
2,22.1,Mesenteric artery stenosis,6,16908747
3,22.1,Pigmentation disorder,6,16908747
4,22.1,Asthenia,6,16908747
5,22.1,Haemoglobin decreased,6,16908747
6,22.1,Tumour pain,3,16908747
7,22.1,Vomiting,3,16908747
8,22.1,Atelectasis,6,16908747
9,22.1,Abdominal distension,1,16908747
10,22.1,Pancreatitis acute,3,16908747
11,22.1,Ascites,3,16908747
12,22.1,Eructation,6,16908747
13,22.1,Vascular compression,6,16908747
14,22.1,Hypokalaemia,1,16908747
15,22.1,Nausea,3,16908747
16,22.1,Pancreatic duct obstruction,6,16908747
17,22.1,Cholelithiasis,6,16908747
18,22.1,Pleural effusion,6,16908747
19,22.1,Splenomegaly,6,16908747
20,22.1,Duodenal obstruction,6,16908747
21,22.1,Abdominal pain lower,3,16908747
22,22.1,Alopecia,6,16908747
23,22.1,Malaise,6,16908747
24,22.1,Anaemia,6,16908747
25,22.1,Erythema,1,16908747
26,22.1,Disease progression,3,16908747
0,22.1,Hypertension,2,16908753
1,22.1,Blood creatinine increased,2,16908753
0,22.1,Fatigue,6,16908775
0,22.1,Bacterial infection,,16908794
1,22.1,Vomiting,,16908794
0,22.1,Fatigue,6,16908800
1,22.1,Diarrhoea,6,16908800
2,22.1,White blood cell count decreased,6,16908800
3,22.1,Infection,6,16908800
0,22.1,Oral pain,6,16908804
1,22.1,Abdominal pain upper,6,16908804
2,22.1,Confusional state,6,16908804
3,22.1,Suicidal ideation,6,16908804
4,22.1,Pain in extremity,6,16908804
5,22.1,Breast pain,6,16908804
6,22.1,Back pain,6,16908804
7,22.1,Anxiety,6,16908804
8,22.1,Eating disorder,6,16908804
9,22.1,Depressed mood,6,16908804
10,22.1,Insomnia,6,16908804
11,22.1,Restlessness,6,16908804
12,22.1,Nausea,6,16908804
13,22.1,Nasal congestion,6,16908804
14,22.1,Emotional disorder,6,16908804
0,22.1,Therapy change,,16908806
1,22.1,Fatigue,,16908806
2,22.1,Catheterisation cardiac,,16908806
0,22.1,Off label use,6,16908807
1,22.1,Carbohydrate antigen 125 increased,6,16908807
2,22.1,Product use in unapproved indication,6,16908807
0,22.1,Death,5,16908824
0,22.1,Cerebrovascular accident,6,16908825
0,22.1,Syringe issue,,16908852
1,22.1,Intercepted medication error,,16908852
0,22.1,Syringe issue,,16908856
1,22.1,Intercepted medication error,,16908856
0,22.1,Peripheral swelling,6,16908859
1,22.1,Colon cancer,6,16908859
2,22.1,Death,5,16908859
3,22.1,Diarrhoea,6,16908859
4,22.1,Off label use,6,16908859
0,22.1,Hypogeusia,6,16908864
1,22.1,Decreased appetite,6,16908864
2,22.1,Fatigue,6,16908864
0,22.1,Alopecia,6,16908882
1,22.1,Hair texture abnormal,3,16908882
2,22.1,Hair colour changes,3,16908882
3,22.1,Hair disorder,3,16908882
4,22.1,Madarosis,3,16908882
0,22.1,Hair texture abnormal,3,16908889
1,22.1,Hair disorder,3,16908889
2,22.1,Hair colour changes,3,16908889
3,22.1,Alopecia,3,16908889
0,22.1,Neoplasm progression,6,16908892
0,22.1,Nervousness,6,16908917
1,22.1,Night sweats,6,16908917
2,22.1,Restlessness,6,16908917
3,22.1,Feeling abnormal,6,16908917
4,22.1,Stomatitis,6,16908917
5,22.1,Frequent bowel movements,6,16908917
6,22.1,Insomnia,6,16908917
7,22.1,Decreased appetite,6,16908917
8,22.1,Abdominal discomfort,6,16908917
9,22.1,Abdominal discomfort,6,16908917
10,22.1,Nausea,6,16908917
0,22.1,Hair texture abnormal,6,16908925
1,22.1,Alopecia,3,16908925
2,22.1,Hair disorder,6,16908925
3,22.1,Hair colour changes,6,16908925
0,22.1,Syncope,1,16908932
0,22.1,Chest pain,2,16908938
1,22.1,Ulcer,2,16908938
2,22.1,Haematemesis,1,16908938
3,22.1,Stoma site haemorrhage,1,16908938
0,22.1,Diarrhoea,6,16908940
1,22.1,Drug titration,6,16908940
2,22.1,Hospitalisation,6,16908940
3,22.1,Malaise,6,16908940
4,22.1,Nausea,6,16908940
0,22.1,Injection site pain,6,16908944
1,22.1,Injection site erythema,6,16908944
0,22.1,Injection site pain,6,16908952
1,22.1,Injection site erythema,6,16908952
0,22.1,Injection site pain,6,16908960
1,22.1,Injection site erythema,6,16908960
0,22.1,Injection site erythema,6,16908965
1,22.1,Injection site pain,6,16908965
0,22.1,Injection site pain,6,16908980
1,22.1,Injection site erythema,6,16908980
0,22.1,Hair texture abnormal,3,16909002
1,22.1,Hair colour changes,3,16909002
2,22.1,Alopecia,3,16909002
3,22.1,Hair disorder,3,16909002
0,22.1,Hair texture abnormal,3,16909021
1,22.1,Hair disorder,3,16909021
2,22.1,Alopecia,3,16909021
3,22.1,Hair colour changes,3,16909021
0,22.1,Neoplasm progression,6,16909023
0,22.1,Hair disorder,3,16909032
1,22.1,Madarosis,3,16909032
2,22.1,Alopecia,3,16909032
3,22.1,Hair colour changes,3,16909032
4,22.1,Hair texture abnormal,3,16909032
0,22.1,Hepatitis B reactivation,6,16909080
1,22.1,Acute hepatic failure,6,16909080
0,22.1,Cardiac failure,3,16909083
1,22.1,Weight decreased,3,16909083
2,22.1,Ejection fraction decreased,3,16909083
3,22.1,Left ventricular dilatation,3,16909083
4,22.1,Left ventricular dysfunction,3,16909083
5,22.1,Night sweats,3,16909083
6,22.1,Heart rate decreased,3,16909083
7,22.1,Hot flush,3,16909083
8,22.1,Insomnia,3,16909083
0,22.1,Fatigue,2,16909085
1,22.1,Diarrhoea,2,16909085
2,22.1,Faeces soft,6,16909085
3,22.1,Flatulence,1,16909085
4,22.1,Thrombocytopenia,1,16909085
5,22.1,Neuropathy peripheral,3,16909085
6,22.1,Anaemia,2,16909085
7,22.1,Pollakiuria,1,16909085
8,22.1,Headache,6,16909085
9,22.1,Dizziness,2,16909085
10,22.1,Back pain,2,16909085
11,22.1,Abdominal pain,1,16909085
12,22.1,Abdominal distension,1,16909085
13,22.1,Neutropenia,2,16909085
14,22.1,Diarrhoea haemorrhagic,1,16909085
15,22.1,Hepatic enzyme increased,1,16909085
16,22.1,Infection,6,16909085
17,22.1,Leukopenia,3,16909085
18,22.1,Condition aggravated,3,16909085
19,22.1,Caudal regression syndrome,6,16909085
20,22.1,Bone marrow failure,3,16909085
21,22.1,Nausea,2,16909085
22,22.1,Dry mouth,2,16909085
23,22.1,Blood pressure decreased,1,16909085
24,22.1,Weight decreased,3,16909085
25,22.1,Pain in extremity,2,16909085
26,22.1,Frequent bowel movements,6,16909085
27,22.1,Decreased appetite,3,16909085
28,22.1,Hot flush,2,16909085
29,22.1,Paraesthesia,2,16909085
0,22.1,Drug resistance,6,16909134
1,22.1,Malignant neoplasm progression,6,16909134
0,22.1,Angiosarcoma,6,16909138
1,22.1,Second primary malignancy,6,16909138
2,22.1,Impaired healing,6,16909138
0,22.1,Malignant neoplasm progression,6,16909141
1,22.1,Drug resistance,6,16909141
0,22.1,Lung disorder,1,16909162
0,22.1,Hepatocellular injury,1,16909164
0,22.1,Cystoid macular oedema,1,16909172
0,22.1,General physical health deterioration,1,16909173
0,22.1,Off label use,6,16909177
1,22.1,Joint swelling,6,16909177
0,22.1,Death,5,16909202
0,22.1,Vomiting,,16909224
1,22.1,Abdominal discomfort,,16909224
2,22.1,Blood count abnormal,,16909224
3,22.1,Nausea,,16909224
0,22.1,Metastases to central nervous system,6,16909230
0,22.1,Blood pressure abnormal,2,16909287
1,22.1,Hepatic failure,6,16909287
2,22.1,Gastrointestinal disorder,6,16909287
3,22.1,Pain,6,16909287
0,22.1,Neoplasm progression,5,16909291
1,22.1,Septic shock,5,16909291
2,22.1,Sepsis,6,16909291
3,22.1,Liver injury,6,16909291
0,22.1,Inappropriate antidiuretic hormone secretion,6,16909299
1,22.1,Thyroid disorder,6,16909299
2,22.1,Off label use,6,16909299
3,22.1,Erythema multiforme,6,16909299
4,22.1,Cystitis,6,16909299
0,22.1,Malignant neoplasm progression,3,16909308
0,22.1,Hallucination,2,16909385
0,22.1,Fatigue,3,16909412
1,22.1,Diarrhoea,3,16909412
2,22.1,Decreased appetite,3,16909412
0,22.1,Drug resistance,6,16909416
1,22.1,Malignant neoplasm progression,6,16909416
0,22.1,Neuropathy peripheral,6,16909418
1,22.1,Neutropenia,2,16909418
2,22.1,Gait disturbance,6,16909418
3,22.1,Colitis ischaemic,1,16909418
4,22.1,Musculoskeletal disorder,6,16909418
5,22.1,Muscular weakness,6,16909418
6,22.1,Dry mouth,6,16909418
7,22.1,Intestinal ischaemia,1,16909418
8,22.1,Cardiac failure congestive,6,16909418
9,22.1,White blood cell count decreased,1,16909418
10,22.1,Decreased appetite,1,16909418
11,22.1,Neoplasm progression,5,16909418
12,22.1,Mesenteric vascular insufficiency,6,16909418
13,22.1,Blood count abnormal,1,16909418
0,22.1,Neutrophil count decreased,1,16909429
0,22.1,Weight decreased,6,16909433
1,22.1,Cerebrovascular accident,6,16909433
2,22.1,Dysgeusia,6,16909433
3,22.1,Constipation,6,16909433
0,22.1,Hypocalcaemia,1,16909454
0,22.1,Eye disorder,6,16909468
1,22.1,Alopecia,6,16909468
2,22.1,Diarrhoea,1,16909468
3,22.1,Pain,6,16909468
4,22.1,Skin ulcer,6,16909468
5,22.1,Eye irritation,6,16909468
6,22.1,Vomiting,1,16909468
7,22.1,Rash,6,16909468
8,22.1,Nausea,1,16909468
9,22.1,Asthenia,1,16909468
10,22.1,Shock,6,16909468
11,22.1,Erythema,6,16909468
0,22.1,Acute coronary syndrome,1,16909475
0,22.1,Prostate cancer,5,16909477
0,22.1,Night sweats,6,16909481
0,22.1,Off label use,6,16909484
1,22.1,Pemphigoid,3,16909484
0,22.1,Product leakage,,16909485
1,22.1,Intercepted medication error,,16909485
0,22.1,Wrong technique in product usage process,,16909497
1,22.1,Syringe issue,,16909497
0,22.1,Prostatic specific antigen increased,6,16909513
0,22.1,Lymphangitis,6,16909544
1,22.1,Arteriosclerosis coronary artery,6,16909544
2,22.1,Cerebral disorder,6,16909544
3,22.1,Pruritus,6,16909544
4,22.1,Pulmonary hilum mass,6,16909544
5,22.1,Rash,2,16909544
6,22.1,Pleural effusion,6,16909544
7,22.1,Mediastinal disorder,6,16909544
8,22.1,Cardiomegaly,6,16909544
9,22.1,Pericardial effusion,6,16909544
0,22.1,Acute kidney injury,5,16909558
1,22.1,Pneumonitis,5,16909558
2,22.1,Sepsis,5,16909558
3,22.1,Pneumonia,5,16909558
4,22.1,Haemorrhage,5,16909558
0,22.1,Lung opacity,6,16909560
1,22.1,Acute respiratory failure,5,16909560
2,22.1,Interstitial lung disease,5,16909560
3,22.1,Pyrexia,2,16909560
0,22.1,Interstitial lung disease,1,16909563
0,22.1,Myocardial infarction,2,16909566
1,22.1,Cerebrovascular accident,2,16909566
0,22.1,Pseudocirrhosis,2,16909572
1,22.1,Hepatic encephalopathy,2,16909572
0,22.1,Alopecia,3,16909574
0,22.1,Pulmonary fibrosis,5,16909575
1,22.1,Pneumonitis,5,16909575
0,22.1,Alopecia,3,16909581
1,22.1,Hair colour changes,6,16909581
2,22.1,Hair disorder,6,16909581
3,22.1,Hair texture abnormal,6,16909581
4,22.1,Madarosis,3,16909581
0,22.1,Prostatic specific antigen increased,6,16909587
1,22.1,Stress urinary incontinence,6,16909587
2,22.1,Asthenia,6,16909587
3,22.1,Urinary tract obstruction,6,16909587
4,22.1,Urethral intrinsic sphincter deficiency,6,16909587
5,22.1,Arthralgia,2,16909587
0,22.1,Hair colour changes,6,16909593
1,22.1,Alopecia,3,16909593
2,22.1,Madarosis,3,16909593
3,22.1,Hair disorder,6,16909593
4,22.1,Hair texture abnormal,6,16909593
0,22.1,Balance disorder,3,16909596
1,22.1,Asthenia,3,16909596
2,22.1,Paraesthesia,3,16909596
3,22.1,Contusion,3,16909596
4,22.1,Constipation,3,16909596
5,22.1,Muscle spasms,3,16909596
6,22.1,Pruritus,3,16909596
7,22.1,Decreased appetite,3,16909596
8,22.1,Dizziness,3,16909596
0,22.1,Blood pressure immeasurable,1,16909598
1,22.1,Dyspnoea,1,16909598
2,22.1,Hyperhidrosis,1,16909598
3,22.1,Oxygen saturation decreased,1,16909598
4,22.1,Chest pain,1,16909598
0,22.1,Pancytopenia,1,16909599
1,22.1,General physical health deterioration,1,16909599
2,22.1,Sepsis,1,16909599
3,22.1,Febrile neutropenia,1,16909599
0,22.1,Blood urine present,5,16909611
1,22.1,Condition aggravated,5,16909611
2,22.1,Aphasia,5,16909611
3,22.1,Platelet count decreased,5,16909611
4,22.1,Respiratory failure,5,16909611
5,22.1,Lung disorder,5,16909611
6,22.1,Haemorrhagic stroke,5,16909611
0,22.1,Drug level increased,3,16909666
1,22.1,Drug interaction,3,16909666
2,22.1,Renal disorder,6,16909666
0,22.1,Disease progression,,16909686
0,22.1,Febrile neutropenia,,16909690
0,22.1,Breast cancer,6,16909723
1,22.1,Weight decreased,6,16909723
2,22.1,CYP3A4 polymorphism,6,16909723
3,22.1,Chest pain,6,16909723
4,22.1,Metastases to liver,6,16909723
5,22.1,Pain,6,16909723
6,22.1,Dyspnoea,6,16909723
7,22.1,Electrocardiogram QT prolonged,6,16909723
8,22.1,Nausea,6,16909723
9,22.1,Intentional dose omission,6,16909723
10,22.1,Decreased appetite,6,16909723
11,22.1,Toxicity to various agents,6,16909723
12,22.1,Pleural disorder,6,16909723
13,22.1,Depression,6,16909723
14,22.1,Hyperbilirubinaemia,6,16909723
15,22.1,Malignant neoplasm progression,6,16909723
16,22.1,Depressed mood,6,16909723
0,22.1,Death,,16909729
0,22.1,Death,5,16909740
1,22.1,Product dose omission,3,16909740
0,22.1,Drug resistance,6,16909775
1,22.1,Diarrhoea,1,16909775
0,22.1,Bacteraemia,6,16909796
1,22.1,Hepatic failure,5,16909796
2,22.1,Muscular weakness,6,16909796
0,22.1,Skin ulcer,6,16909825
1,22.1,Erythema,6,16909825
2,22.1,Scar,3,16909825
3,22.1,Pruritus,6,16909825
4,22.1,Skin exfoliation,6,16909825
5,22.1,Skin mass,6,16909825
0,22.1,Neutropenia,6,16909826
0,22.1,Metastases to lung,6,16909828
1,22.1,Metastases to spine,6,16909828
2,22.1,Malignant neoplasm progression,6,16909828
0,22.1,Dehydration,1,16909837
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,16909837
2,22.1,Colitis,3,16909837
3,22.1,Acute kidney injury,1,16909837
4,22.1,General physical health deterioration,2,16909837
5,22.1,Diarrhoea,3,16909837
0,22.1,Lethargy,2,16909838
0,22.1,Pyrexia,,16909852
1,22.1,Bacteraemia,,16909852
0,22.1,Therapeutic response decreased,6,16909927
0,22.1,Radiation pneumonitis,2,16909943
0,22.1,Muscular weakness,1,16909950
1,22.1,Electrolyte imbalance,1,16909950
0,22.1,Syringe issue,,16909956
1,22.1,Product preparation error,,16909956
2,22.1,Device leakage,,16909956
0,22.1,Prostate cancer,6,16909971
0,22.1,Intercepted medication error,,16909982
1,22.1,Syringe issue,,16909982
0,22.1,Off label use,6,16910082
1,22.1,Hyperkalaemia,1,16910082
2,22.1,Cholecystitis,1,16910082
3,22.1,Hyponatraemia,1,16910082
4,22.1,Interstitial lung disease,3,16910082
5,22.1,Cholangitis sclerosing,2,16910082
6,22.1,Platelet count decreased,1,16910082
0,22.1,Cardiovascular disorder,6,16910175
0,22.1,Confusional state,1,16910205
1,22.1,Dysarthria,1,16910205
2,22.1,Agitation,1,16910205
0,22.1,Renal disorder,3,16910227
0,22.1,Drug-induced liver injury,3,16910239
1,22.1,Decreased appetite,3,16910239
0,22.1,Renal impairment,6,16910276
0,22.1,Pneumonitis,3,16910348
0,22.1,Electrolyte imbalance,2,16910385
1,22.1,Rash,2,16910385
2,22.1,Metastases to lung,5,16910385
3,22.1,Lung neoplasm malignant,5,16910385
4,22.1,Somnolence,6,16910385
5,22.1,Mucosal inflammation,2,16910385
6,22.1,Bronchial carcinoma,5,16910385
7,22.1,Rash,2,16910385
8,22.1,Mouth ulceration,2,16910385
9,22.1,Diarrhoea,2,16910385
10,22.1,Dermatitis exfoliative,2,16910385
11,22.1,Blood glucose increased,6,16910385
12,22.1,Skin haemorrhage,6,16910385
13,22.1,Gastrointestinal haemorrhage,5,16910385
0,22.1,Abdominal discomfort,6,16910410
0,22.1,Death,5,16910443
0,22.1,Cytokine release syndrome,1,16910469
1,22.1,Acute kidney injury,6,16910469
0,22.1,Asthenia,6,16910601
1,22.1,Post procedural complication,6,16910601
2,22.1,Fall,1,16910601
3,22.1,Diarrhoea,3,16910601
0,22.1,Cholestasis,5,16910640
0,22.1,Hepatic encephalopathy,6,16910650
1,22.1,Pseudocirrhosis,6,16910650
0,22.1,Death,5,16910655
0,22.1,Bradycardia,1,16910663
0,22.1,Hyperammonaemia,6,16910664
0,22.1,Product use in unapproved therapeutic environment,6,16910692
0,22.1,Immune-mediated enterocolitis,2,16910708
1,22.1,Diarrhoea,2,16910708
2,22.1,Product use in unapproved indication,6,16910708
0,22.1,Guillain-Barre syndrome,3,16910709
0,22.1,Bone marrow failure,2,16910719
0,22.1,Death,5,16910724
0,22.1,Cytopenia,2,16910728
0,22.1,Death,5,16910729
0,22.1,Death,5,16910746
1,22.1,Malignant neoplasm progression,1,16910746
0,22.1,Abdominal rigidity,6,16910748
1,22.1,Chest discomfort,6,16910748
2,22.1,Burning sensation,6,16910748
3,22.1,Tremor,6,16910748
0,22.1,Arteriospasm coronary,2,16910893
0,22.1,Dermatitis,6,16910903
1,22.1,Death,5,16910903
2,22.1,Dyspnoea,6,16910903
3,22.1,Chronic obstructive pulmonary disease,6,16910903
4,22.1,Non-small cell lung cancer,6,16910903
5,22.1,Pruritus,6,16910903
0,22.1,Diarrhoea,3,16910908
1,22.1,Dehydration,3,16910908
0,22.1,Malignant gastrointestinal obstruction,6,16910923
1,22.1,Metastases to bone,6,16910923
2,22.1,Colon cancer,6,16910923
3,22.1,Malignant neoplasm progression,6,16910923
0,22.1,Electrocardiogram QT prolonged,1,16910937
0,22.1,Non-small cell lung cancer,6,16910970
1,22.1,Mucosal inflammation,6,16910970
2,22.1,Death,5,16910970
3,22.1,Diarrhoea,6,16910970
0,22.1,Death,5,16910972
0,22.1,Death,5,16910974
0,22.1,Necrotising fasciitis,5,16910977
0,22.1,Urticaria,1,16910986
1,22.1,Dyspnoea,1,16910986
2,22.1,Limb discomfort,1,16910986
0,22.1,Xerosis,3,16910992
1,22.1,Acne,3,16910992
0,22.1,Hepatocellular injury,1,16910994
0,22.1,Palmar erythema,1,16910995
1,22.1,Hypertension,1,16910995
2,22.1,Chills,1,16910995
0,22.1,Oxygen saturation decreased,1,16910996
1,22.1,Hypersensitivity,1,16910996
2,22.1,Loss of consciousness,1,16910996
0,22.1,Nail dystrophy,1,16910997
1,22.1,Traumatic haematoma,1,16910997
2,22.1,Nail pigmentation,1,16910997
3,22.1,Onycholysis,1,16910997
4,22.1,Paronychia,1,16910997
5,22.1,Nail ridging,1,16910997
0,22.1,Nausea,6,16911024
1,22.1,Haematotoxicity,6,16911024
2,22.1,Vomiting,6,16911024
0,22.1,Ischaemic stroke,1,16911032
0,22.1,Bladder cancer,6,16911067
0,22.1,Drug intolerance,6,16911084
1,22.1,General physical health deterioration,1,16911084
2,22.1,Off label use,6,16911084
3,22.1,Acute kidney injury,1,16911084
4,22.1,Vomiting,1,16911084
5,22.1,Diarrhoea,1,16911084
0,22.1,Wrong technique in product usage process,6,16911085
1,22.1,Transaminases abnormal,6,16911085
2,22.1,Neurotoxicity,6,16911085
3,22.1,Breast cancer,6,16911085
4,22.1,Malignant neoplasm progression,6,16911085
0,22.1,Device related infection,1,16911086
1,22.1,Shock,1,16911086
0,22.1,Hair texture abnormal,3,16911097
1,22.1,Cough,6,16911097
2,22.1,Acne,6,16911097
3,22.1,Oesophagitis,6,16911097
4,22.1,Diarrhoea,6,16911097
0,22.1,Urinary tract infection,1,16911111
1,22.1,Duodenal ulcer haemorrhage,1,16911111
2,22.1,Gastritis erosive,1,16911111
0,22.1,Pleural disorder,6,16911113
1,22.1,Pain,6,16911113
2,22.1,Intentional dose omission,6,16911113
3,22.1,Decreased appetite,6,16911113
4,22.1,CYP3A4 polymorphism,6,16911113
5,22.1,Dyspnoea,6,16911113
6,22.1,Electrocardiogram QT prolonged,6,16911113
7,22.1,Malignant neoplasm progression,6,16911113
8,22.1,Depression,6,16911113
9,22.1,Metastases to liver,6,16911113
10,22.1,Toxicity to various agents,6,16911113
11,22.1,Depressed mood,6,16911113
12,22.1,Breast cancer,6,16911113
13,22.1,Hyperbilirubinaemia,6,16911113
14,22.1,Nausea,6,16911113
15,22.1,Weight decreased,6,16911113
16,22.1,Chest pain,6,16911113
0,22.1,Diarrhoea,6,16911124
1,22.1,Hypophagia,6,16911124
2,22.1,Rash,6,16911124
0,22.1,Fatigue,6,16911136
1,22.1,Diarrhoea,6,16911136
2,22.1,Asthenia,6,16911136
3,22.1,Malignant neoplasm progression,6,16911136
0,22.1,Malignant neoplasm progression,6,16911137
1,22.1,Death,5,16911137
2,22.1,Diarrhoea,6,16911137
3,22.1,Nausea,6,16911137
0,22.1,Malignant neoplasm progression,6,16911140
1,22.1,Death,5,16911140
2,22.1,Polyneuropathy,6,16911140
3,22.1,Diarrhoea,6,16911140
0,22.1,Eyelid ptosis,2,16911148
1,22.1,Dyspnoea,2,16911148
2,22.1,Muscular weakness,2,16911148
3,22.1,Product use in unapproved indication,6,16911148
4,22.1,Troponin increased,2,16911148
5,22.1,Blood creatine phosphokinase increased,2,16911148
0,22.1,Osteonecrosis of jaw,2,16911166
0,22.1,Pneumonitis,6,16911170
1,22.1,Dyspnoea,6,16911170
2,22.1,Confusional state,6,16911170
3,22.1,Oxygen saturation decreased,6,16911170
0,22.1,Anxiety,3,16911244
1,22.1,Hot flush,3,16911244
2,22.1,Blood sodium increased,3,16911244
3,22.1,Confusional state,3,16911244
0,22.1,Death,5,16911266
1,22.1,Malignant neoplasm progression,6,16911266
2,22.1,Acute kidney injury,2,16911266
3,22.1,Diarrhoea,2,16911266
0,22.1,Asthenia,2,16911281
1,22.1,Cough,3,16911281
2,22.1,Pyrexia,1,16911281
3,22.1,Confusional state,6,16911281
4,22.1,General physical condition abnormal,3,16911281
5,22.1,Malignant neoplasm progression,6,16911281
0,22.1,Motor dysfunction,1,16911283
1,22.1,Toxic neuropathy,1,16911283
2,22.1,Diplopia,1,16911283
3,22.1,Muscular weakness,1,16911283
0,22.1,Electrocardiogram QT prolonged,6,16911291
1,22.1,Large intestinal obstruction,6,16911291
0,22.1,Abdominal pain,2,16911294
1,22.1,Abdominal distension,2,16911294
2,22.1,Oedema,2,16911294
0,22.1,Drug-induced liver injury,6,16911303
0,22.1,Prostate cancer metastatic,6,16911320
1,22.1,Hormone-refractory prostate cancer,6,16911320
0,22.1,Stevens-Johnson syndrome,1,16911391
1,22.1,Toxic epidermal necrolysis,1,16911391
0,22.1,Oral herpes,1,16911441
0,22.1,General physical health deterioration,5,16911616
1,22.1,Malignant neoplasm progression,3,16911616
0,22.1,Neutropenia,6,16911656
1,22.1,Fatigue,6,16911656
2,22.1,Mucosal dryness,6,16911656
3,22.1,Androgenetic alopecia,6,16911656
4,22.1,Lymphocytosis,6,16911656
5,22.1,Joint stiffness,6,16911656
6,22.1,Constipation,6,16911656
7,22.1,Musculoskeletal discomfort,6,16911656
0,22.1,Neutropenia,2,16911684
1,22.1,White blood cell count decreased,6,16911684
0,22.1,Death,5,16911718
0,22.1,Device use error,6,16911736
1,22.1,Hyperhidrosis,6,16911736
0,22.1,Pneumonia,5,16911786
1,22.1,Respiratory failure,5,16911786
0,22.1,Electrocardiogram QT prolonged,6,16911791
1,22.1,Rash,6,16911791
2,22.1,Diarrhoea,6,16911791
3,22.1,Carcinoembryonic antigen increased,6,16911791
4,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,16911791
5,22.1,Blood calcitonin abnormal,6,16911791
6,22.1,Pain in extremity,6,16911791
7,22.1,Tremor,6,16911791
0,22.1,Bone marrow failure,1,16911798
0,22.1,Psychological trauma,6,16911861
1,22.1,Alopecia,3,16911861
0,22.1,Anxiety,6,16911862
1,22.1,Impaired quality of life,6,16911862
2,22.1,Emotional distress,6,16911862
3,22.1,Psychological trauma,6,16911862
4,22.1,Alopecia,2,16911862
5,22.1,Pain,6,16911862
0,22.1,Alopecia,2,16911869
1,22.1,Emotional distress,6,16911869
2,22.1,Impaired quality of life,6,16911869
3,22.1,Pain,6,16911869
4,22.1,Anxiety,6,16911869
0,22.1,Alopecia,2,16911870
0,22.1,Alopecia,2,16911871
0,22.1,Alopecia,2,16911874
0,22.1,Psychological trauma,6,16911877
1,22.1,Alopecia,3,16911877
0,22.1,Alopecia,2,16911882
1,22.1,Psychological trauma,6,16911882
0,22.1,Psychological trauma,6,16911889
1,22.1,Alopecia,2,16911889
0,22.1,Psychological trauma,6,16911892
1,22.1,Alopecia,3,16911892
0,22.1,Psychological trauma,6,16911895
1,22.1,Alopecia,2,16911895
0,22.1,Psychological trauma,6,16911946
1,22.1,Alopecia,3,16911946
0,22.1,Alopecia,2,16911965
1,22.1,Psychological trauma,6,16911965
0,22.1,Staphylococcal infection,5,16912042
1,22.1,Septic shock,6,16912042
2,22.1,Off label use,6,16912042
0,22.1,Death,5,16912083
0,22.1,Heart rate increased,1,16912091
0,22.1,Breast cancer female,3,16912112
1,22.1,Spinal compression fracture,1,16912112
2,22.1,Weight decreased,6,16912112
3,22.1,Constipation,3,16912112
4,22.1,Gait disturbance,3,16912112
5,22.1,Abdominal distension,3,16912112
6,22.1,Body height decreased,3,16912112
7,22.1,Diarrhoea,3,16912112
8,22.1,Urticaria,1,16912112
9,22.1,Product dose omission,3,16912112
10,22.1,Metastases to bone,3,16912112
11,22.1,Abdominal pain,3,16912112
12,22.1,Precancerous skin lesion,6,16912112
0,22.1,Systolic dysfunction,4,16912130
0,22.1,Head injury,1,16912132
1,22.1,Fall,1,16912132
2,22.1,Confusional state,1,16912132
3,22.1,Malaise,1,16912132
4,22.1,Syncope,6,16912132
0,22.1,General physical condition abnormal,5,16912179
1,22.1,Dyspnoea,5,16912179
2,22.1,Therapy non-responder,6,16912179
3,22.1,Therapeutic product effect decreased,6,16912179
4,22.1,Pneumonia,5,16912179
0,22.1,Off label use,6,16912187
0,22.1,Device battery issue,6,16912261
0,22.1,Arthritis,3,16912268
1,22.1,Constipation,6,16912268
2,22.1,Asthenia,6,16912268
3,22.1,Nausea,3,16912268
4,22.1,Taste disorder,6,16912268
5,22.1,Cardiac disorder,6,16912268
6,22.1,Decreased appetite,6,16912268
7,22.1,Fatigue,6,16912268
8,22.1,Product dose omission,6,16912268
0,22.1,Nausea,6,16912275
1,22.1,CYP3A4 polymorphism,6,16912275
2,22.1,Chest pain,6,16912275
3,22.1,Malignant neoplasm progression,6,16912275
4,22.1,Metastases to liver,6,16912275
5,22.1,Toxicity to various agents,6,16912275
6,22.1,Depressed mood,6,16912275
7,22.1,Electrocardiogram QT prolonged,6,16912275
8,22.1,Decreased appetite,6,16912275
9,22.1,Depression,6,16912275
10,22.1,Dyspnoea,6,16912275
11,22.1,Breast cancer,6,16912275
12,22.1,Weight decreased,6,16912275
13,22.1,Hyperbilirubinaemia,6,16912275
14,22.1,Intentional dose omission,6,16912275
15,22.1,Pleural disorder,6,16912275
16,22.1,Pain,6,16912275
0,22.1,Glucose tolerance impaired,6,16912289
1,22.1,Subcutaneous abscess,6,16912289
2,22.1,Neutrophil count decreased,6,16912289
3,22.1,Anorectal infection,6,16912289
0,22.1,Cystitis radiation,6,16912369
1,22.1,Haematuria,6,16912369
0,22.1,Death,5,16912378
0,22.1,Chorioretinitis,2,16912458
1,22.1,Endophthalmitis,2,16912458
0,22.1,Hypothermia,1,16912502
1,22.1,Back pain,1,16912502
2,22.1,Hypotension,1,16912502
0,22.1,Impaired gastric emptying,6,16912505
0,22.1,Hepatocellular injury,1,16912516
0,22.1,Intestinal perforation,5,16912521
0,22.1,Cerebrovascular disorder,5,16912523
0,22.1,Carbohydrate antigen 125 increased,6,16912566
1,22.1,Emotional distress,6,16912566
2,22.1,Energy increased,6,16912566
3,22.1,Nausea,2,16912566
4,22.1,Recurrent cancer,6,16912566
5,22.1,Red blood cell count abnormal,6,16912566
6,22.1,Tearfulness,6,16912566
0,22.1,Blood count abnormal,6,16912592
1,22.1,Night sweats,3,16912592
2,22.1,Skin disorder,3,16912592
3,22.1,Pallor,6,16912592
4,22.1,Feeling cold,6,16912592
5,22.1,Syncope,6,16912592
6,22.1,Blood creatinine increased,6,16912592
7,22.1,Fungal infection,3,16912592
8,22.1,Dizziness,6,16912592
9,22.1,Product physical issue,6,16912592
10,22.1,Thrombosis,6,16912592
11,22.1,Pain,6,16912592
12,22.1,Cough,1,16912592
13,22.1,Headache,6,16912592
14,22.1,Feeling hot,6,16912592
15,22.1,Erythema,6,16912592
16,22.1,Nail discolouration,6,16912592
17,22.1,Bone pain,6,16912592
18,22.1,Nausea,3,16912592
19,22.1,Onychomadesis,6,16912592
20,22.1,Constipation,3,16912592
21,22.1,Dry skin,3,16912592
22,22.1,Dry mouth,6,16912592
23,22.1,Product dose omission,6,16912592
0,22.1,Vomiting,4,16912625
1,22.1,Post procedural inflammation,4,16912625
2,22.1,Pyrexia,4,16912625
0,22.1,Immune thrombocytopenic purpura,2,16912643
0,22.1,Musculoskeletal stiffness,6,16912666
1,22.1,Myalgia,6,16912666
2,22.1,Arthralgia,6,16912666
3,22.1,Neoplasm progression,6,16912666
4,22.1,Rash,6,16912666
5,22.1,Metastases to liver,6,16912666
6,22.1,Constipation,6,16912666
7,22.1,Skin hypertrophy,6,16912666
8,22.1,Drug tolerance decreased,6,16912666
0,22.1,Breast cancer metastatic,6,16912679
1,22.1,Disease progression,6,16912679
0,22.1,Amylase increased,3,16912680
1,22.1,Blood bilirubin increased,3,16912680
2,22.1,Alanine aminotransferase increased,3,16912680
3,22.1,Lipase increased,3,16912680
4,22.1,Aspartate aminotransferase increased,3,16912680
0,22.1,Gastrointestinal toxicity,6,16912690
0,22.1,Diarrhoea,6,16912721
1,22.1,Myalgia,6,16912721
2,22.1,Neoplasm progression,6,16912721
0,22.1,Recurrent cancer,6,16912733
1,22.1,Malignant neoplasm progression,6,16912733
0,22.1,Neoplasm progression,6,16912735
1,22.1,Diarrhoea,6,16912735
0,22.1,Lung disorder,1,16912746
0,22.1,Peripheral ischaemia,1,16912749
1,22.1,Off label use,6,16912749
0,22.1,Tubulointerstitial nephritis,5,16912772
0,22.1,Chest discomfort,2,16912811
1,22.1,Vomiting,2,16912811
2,22.1,Palpitations,2,16912811
3,22.1,Dysphonia,2,16912811
4,22.1,Pruritus,2,16912811
5,22.1,Laryngeal oedema,2,16912811
0,22.1,Pulmonary embolism,1,16912836
1,22.1,Glomerular filtration rate decreased,6,16912836
2,22.1,Escherichia infection,6,16912836
3,22.1,Presyncope,6,16912836
4,22.1,Troponin increased,6,16912836
5,22.1,Activated partial thromboplastin time prolonged,6,16912836
6,22.1,C-reactive protein increased,2,16912836
7,22.1,Blood creatinine increased,6,16912836
8,22.1,Discomfort,6,16912836
9,22.1,pH body fluid decreased,6,16912836
10,22.1,Constipation,6,16912836
11,22.1,Urinary tract infection,6,16912836
12,22.1,Bundle branch block right,6,16912836
13,22.1,International normalised ratio decreased,6,16912836
14,22.1,Red blood cells urine positive,6,16912836
15,22.1,Atrial natriuretic peptide increased,6,16912836
16,22.1,Fibrin D dimer increased,6,16912836
17,22.1,Hypertension,6,16912836
18,22.1,Malaise,6,16912836
19,22.1,Oedema peripheral,6,16912836
0,22.1,Off label use,6,16912841
1,22.1,Polyneuropathy,5,16912841
2,22.1,Drug ineffective,6,16912841
3,22.1,Therapy partial responder,6,16912841
4,22.1,Chronic myeloid leukaemia,5,16912841
5,22.1,Disease progression,5,16912841
6,22.1,Breast cancer,6,16912841
7,22.1,Thrombocytopenia,6,16912841
8,22.1,Anaemia,6,16912841
9,22.1,Drug interaction,5,16912841
0,22.1,Dyspnoea,2,16912899
1,22.1,Hypoaesthesia,2,16912899
2,22.1,Flushing,2,16912899
3,22.1,Dizziness,2,16912899
4,22.1,Blood glucose decreased,2,16912899
5,22.1,Vision blurred,2,16912899
0,22.1,Malaise,6,16912924
0,22.1,Osteonecrosis of jaw,3,16912933
1,22.1,Abscess,6,16912933
0,22.1,Nausea,6,16912939
1,22.1,Body temperature increased,6,16912939
2,22.1,Chills,6,16912939
0,22.1,Breast cancer metastatic,6,16912973
1,22.1,Malignant neoplasm progression,6,16912973
0,22.1,Metastases to lung,6,16912978
1,22.1,Weight decreased,6,16912978
2,22.1,Metastases to liver,6,16912978
3,22.1,Metastases to skin,6,16912978
4,22.1,Breast cancer,6,16912978
5,22.1,Metastases to bone,6,16912978
6,22.1,Hypophagia,6,16912978
7,22.1,Malignant neoplasm progression,6,16912978
8,22.1,Pain,6,16912978
0,22.1,Bone pain,2,16912982
0,22.1,Death,5,16912988
1,22.1,Off label use,1,16912988
0,22.1,Immune thrombocytopenic purpura,2,16913023
0,22.1,Ovarian germ cell teratoma stage I,1,16913070
0,22.1,Haematotoxicity,6,16913094
0,22.1,Anaemia,2,16913110
1,22.1,Blood albumin decreased,2,16913110
2,22.1,Extrasystoles,2,16913110
3,22.1,Electrocardiogram ST segment abnormal,2,16913110
4,22.1,Atrial fibrillation,2,16913110
0,22.1,Pulmonary embolism,3,16913111
0,22.1,Macular fibrosis,3,16913136
0,22.1,Hepatitis acute,2,16913137
0,22.1,Thrombotic microangiopathy,2,16913138
0,22.1,Myelitis,6,16913226
1,22.1,Paralysis,6,16913226
0,22.1,Electrocardiogram QT prolonged,1,16913229
1,22.1,Bradycardia,1,16913229
0,22.1,Meningoencephalitis herpetic,2,16913232
1,22.1,Immunosuppression,2,16913232
2,22.1,Platelet count decreased,6,16913232
3,22.1,White blood cell count increased,6,16913232
4,22.1,Headache,6,16913232
5,22.1,Asthenia,6,16913232
6,22.1,Metastases to central nervous system,2,16913232
7,22.1,Metastases to liver,2,16913232
8,22.1,Protein total increased,6,16913232
9,22.1,Herpes simplex encephalitis,6,16913232
10,22.1,Malignant neoplasm progression,2,16913232
11,22.1,Metastases to eye,2,16913232
12,22.1,Breast cancer,2,16913232
0,22.1,Vitiligo,6,16913233
0,22.1,Pneumonia,3,16913301
0,22.1,Hypoglycaemia,6,16913302
0,22.1,Drug intolerance,6,16913355
1,22.1,Blood creatinine increased,6,16913355
2,22.1,Diarrhoea,6,16913355
0,22.1,Amoebiasis,6,16913358
1,22.1,Respiratory disorder,6,16913358
2,22.1,Pyrexia,6,16913358
3,22.1,Influenza,6,16913358
4,22.1,Chills,6,16913358
0,22.1,Anaemia,3,16913389
1,22.1,Thrombosis,3,16913389
2,22.1,Lung neoplasm,3,16913389
3,22.1,Bone neoplasm,3,16913389
4,22.1,Prostate cancer metastatic,3,16913389
5,22.1,Neoplasm,3,16913389
0,22.1,Disease progression,6,16913396
1,22.1,Dyspnoea,3,16913396
0,22.1,General physical health deterioration,1,16913415
1,22.1,Leukopenia,1,16913415
2,22.1,Upper respiratory tract infection,1,16913415
3,22.1,Dyspepsia,1,16913415
4,22.1,Dyspnoea,1,16913415
0,22.1,Vulvovaginal dryness,3,16913423
1,22.1,Pain in extremity,3,16913423
2,22.1,Arthralgia,3,16913423
3,22.1,Joint stiffness,3,16913423
4,22.1,Musculoskeletal stiffness,3,16913423
5,22.1,Hypoaesthesia,3,16913423
0,22.1,Nail ridging,2,16913425
1,22.1,Onycholysis,2,16913425
2,22.1,Paronychia,2,16913425
3,22.1,Traumatic haematoma,2,16913425
4,22.1,Nail pigmentation,2,16913425
5,22.1,Nail dystrophy,2,16913425
0,22.1,Muscle atrophy,6,16913470
0,22.1,Focal segmental glomerulosclerosis,6,16913527
1,22.1,Sjogren^s syndrome,6,16913527
2,22.1,Tubulointerstitial nephritis,6,16913527
3,22.1,Urinary tract infection,6,16913527
0,22.1,Renal tubular necrosis,6,16913616
0,22.1,Hepatitis B,6,16913622
0,22.1,Phlebitis,3,16913677
1,22.1,Drug ineffective,3,16913677
2,22.1,Pulmonary embolism,2,16913677
3,22.1,Dyspnoea,6,16913677
4,22.1,Deep vein thrombosis,2,16913677
0,22.1,Liver function test abnormal,6,16913681
0,22.1,Cardiac failure,1,16913717
0,22.1,Pulmonary toxicity,1,16913737
1,22.1,Drug hypersensitivity,1,16913737
2,22.1,Dyspnoea,1,16913737
0,22.1,Thermal burn,6,16913752
1,22.1,Blood test abnormal,6,16913752
2,22.1,Vision blurred,6,16913752
3,22.1,Wheelchair user,6,16913752
4,22.1,Heart rate increased,3,16913752
5,22.1,Blister,6,16913752
6,22.1,Oxygen saturation decreased,6,16913752
7,22.1,Fatigue,3,16913752
8,22.1,Dyspnoea exertional,3,16913752
9,22.1,Full blood count decreased,6,16913752
10,22.1,Lethargy,6,16913752
11,22.1,Dyspepsia,6,16913752
12,22.1,Red blood cell count decreased,3,16913752
13,22.1,Haemoglobin decreased,6,16913752
14,22.1,Pain,6,16913752
15,22.1,Dizziness,6,16913752
16,22.1,Diarrhoea,6,16913752
17,22.1,Blood pressure increased,6,16913752
18,22.1,Syncope,6,16913752
19,22.1,Gait disturbance,6,16913752
0,22.1,Interstitial lung disease,1,16913769
1,22.1,Heart rate irregular,6,16913769
0,22.1,Osteonecrosis of jaw,3,16913771
0,22.1,Rash,6,16913775
1,22.1,Haemorrhage,6,16913775
2,22.1,Off label use,6,16913775
3,22.1,Product use in unapproved indication,6,16913775
0,22.1,Gastrointestinal toxicity,6,16913779
0,22.1,Interstitial lung disease,2,16913844
0,22.1,Asthenia,6,16913888
1,22.1,Neutropenia,6,16913888
2,22.1,Anaemia,6,16913888
3,22.1,Breast swelling,6,16913888
0,22.1,Neoplasm progression,6,16913932
1,22.1,Blood count abnormal,6,16913932
0,22.1,Chronic obstructive pulmonary disease,1,16914074
0,22.1,Blood count abnormal,1,16914090
0,22.1,Fatigue,6,16914098
1,22.1,Neoplasm progression,6,16914098
2,22.1,Decreased appetite,6,16914098
0,22.1,Lip discolouration,1,16914114
1,22.1,Dark circles under eyes,1,16914114
2,22.1,Decreased appetite,3,16914114
3,22.1,Lip swelling,1,16914114
4,22.1,Death,5,16914114
5,22.1,Asthenia,3,16914114
0,22.1,Nausea,3,16914146
0,22.1,Pneumonia,1,16914158
0,22.1,Pneumonia fungal,1,16914159
0,22.1,Lower gastrointestinal perforation,3,16914184
0,22.1,Urinary bladder polyp,3,16914205
0,22.1,Lacrimation increased,6,16914210
1,22.1,Fatigue,6,16914210
0,22.1,Nerve compression,6,16914222
1,22.1,Headache,6,16914222
2,22.1,Hypoaesthesia,6,16914222
3,22.1,Lumbar spinal stenosis,6,16914222
0,22.1,Drug hypersensitivity,6,16914241
0,22.1,Metastases to bone,6,16914249
1,22.1,Diabetes mellitus,3,16914249
2,22.1,Abdominal pain upper,3,16914249
3,22.1,Genital erythema,1,16914249
4,22.1,Blood glucose increased,3,16914249
5,22.1,Flatulence,3,16914249
6,22.1,Blood pressure increased,3,16914249
7,22.1,Genital swelling,1,16914249
8,22.1,Inappropriate schedule of product administration,6,16914249
0,22.1,Blood glucose increased,2,16914252
0,22.1,Death,5,16914257
0,22.1,Hypersomnia,6,16914262
1,22.1,Limb discomfort,6,16914262
2,22.1,White blood cell count increased,6,16914262
3,22.1,Pain,6,16914262
4,22.1,Skin cancer,2,16914262
5,22.1,Off label use,6,16914262
0,22.1,Pruritus,1,16914273
1,22.1,Nausea,1,16914273
2,22.1,Infusion related reaction,1,16914273
3,22.1,Vomiting,1,16914273
4,22.1,Erythema,1,16914273
0,22.1,Eating disorder,6,16914327
1,22.1,Oral pain,6,16914327
2,22.1,Malaise,6,16914327
3,22.1,Lymphoedema,6,16914327
4,22.1,Fatigue,3,16914327
5,22.1,Influenza,6,16914327
0,22.1,Fatigue,6,16914357
1,22.1,White blood cell count decreased,6,16914357
2,22.1,Oral pain,6,16914357
0,22.1,Systolic dysfunction,4,16914428
0,22.1,Neoplasm progression,3,16914454
0,22.1,Vertigo,6,16914495
0,22.1,Malignant neoplasm progression,6,16914498
0,22.1,Thrombocytopenia,6,16914583
1,22.1,Aspartate aminotransferase increased,1,16914583
2,22.1,Facial paralysis,6,16914583
0,22.1,Death,5,16914662
0,22.1,Tooth extraction,1,16914668
1,22.1,Abdominal pain,3,16914668
2,22.1,Ejection fraction decreased,3,16914668
3,22.1,Vomiting,3,16914668
4,22.1,Superinfection,2,16914668
5,22.1,Mouth swelling,6,16914668
6,22.1,Asthenia,3,16914668
7,22.1,Nausea,3,16914668
8,22.1,Headache,3,16914668
9,22.1,Pain in extremity,3,16914668
10,22.1,Abdominal pain lower,1,16914668
11,22.1,Swelling face,3,16914668
12,22.1,Cellulitis,1,16914668
13,22.1,Urinary tract infection,3,16914668
14,22.1,Cough,1,16914668
15,22.1,Lower respiratory tract infection,1,16914668
0,22.1,Photosensitivity reaction,6,16914695
1,22.1,Rash,1,16914695
2,22.1,Hot flush,6,16914695
3,22.1,Nausea,6,16914695
4,22.1,Fatigue,6,16914695
5,22.1,Blister,6,16914695
6,22.1,Dyspnoea,6,16914695
7,22.1,Sleep disorder,6,16914695
8,22.1,Musculoskeletal chest pain,6,16914695
0,22.1,Vertigo,1,16914700
1,22.1,Insomnia,1,16914700
2,22.1,Hypertensive crisis,1,16914700
3,22.1,Flushing,1,16914700
0,22.1,Full blood count decreased,2,16914704
0,22.1,Blood pressure increased,6,16914709
1,22.1,Epistaxis,6,16914709
2,22.1,Red blood cell count decreased,1,16914709
0,22.1,Neoplasm progression,5,16914723
0,22.1,Death,5,16914725
0,22.1,Pancytopenia,6,16914726
1,22.1,Thrombocytopenia,6,16914726
2,22.1,Anaemia,6,16914726
3,22.1,Neutropenia,6,16914726
0,22.1,Death,5,16914727
0,22.1,Anaphylactoid reaction,1,16914730
0,22.1,Platelet count increased,5,16914740
1,22.1,Colorectal cancer,5,16914740
2,22.1,White blood cell count increased,5,16914740
0,22.1,Blood alkaline phosphatase increased,1,16914749
1,22.1,Neutropenia,1,16914749
2,22.1,Platelet count decreased,1,16914749
3,22.1,Leukopenia,1,16914749
0,22.1,Febrile bone marrow aplasia,2,16914761
0,22.1,Metastases to liver,6,16914784
1,22.1,Recurrent cancer,6,16914784
2,22.1,Metastases to rectum,6,16914784
0,22.1,Syncope,6,16914800
0,22.1,Intercepted product preparation error,,16914815
1,22.1,Wrong technique in product usage process,,16914815
0,22.1,Transfusion,3,16914830
1,22.1,Malaise,3,16914830
0,22.1,Vascular device infection,1,16914834
1,22.1,Diarrhoea,1,16914834
2,22.1,Neuropathy peripheral,1,16914834
3,22.1,Dyspnoea,1,16914834
4,22.1,Neurodermatitis,1,16914834
5,22.1,Fatigue,1,16914834
0,22.1,Constipation,6,16914892
1,22.1,Neutropenia,6,16914892
2,22.1,Joint stiffness,6,16914892
3,22.1,Lymphocytosis,6,16914892
4,22.1,Androgenetic alopecia,6,16914892
5,22.1,Fatigue,6,16914892
6,22.1,Mucosal dryness,6,16914892
7,22.1,Musculoskeletal discomfort,6,16914892
0,22.1,Malignant neoplasm progression,6,16914905
1,22.1,Drug resistance,6,16914905
0,22.1,Petit mal epilepsy,1,16914908
0,22.1,Syringe issue,,16914931
1,22.1,Intercepted medication error,,16914931
0,22.1,Incorrect dose administered,,16914932
1,22.1,Needle issue,,16914932
2,22.1,Wrong technique in product usage process,,16914932
3,22.1,Underdose,,16914932
0,22.1,Needle issue,,16914949
1,22.1,Intercepted medication error,,16914949
0,22.1,Syringe issue,,16914955
1,22.1,Intercepted medication error,,16914955
2,22.1,Device leakage,,16914955
0,22.1,Syringe issue,,16914965
1,22.1,Device leakage,,16914965
2,22.1,Intercepted medication error,,16914965
0,22.1,Device leakage,,16914981
1,22.1,Intercepted medication error,,16914981
2,22.1,Syringe issue,,16914981
0,22.1,Intercepted product preparation error,,16914990
1,22.1,Product physical consistency issue,,16914990
0,22.1,Hypokalaemia,1,16915008
0,22.1,Neuropathy peripheral,6,16915031
1,22.1,Gait inability,6,16915031
2,22.1,Asthenia,6,16915031
3,22.1,Hypoaesthesia,6,16915031
4,22.1,Neutropenic sepsis,6,16915031
5,22.1,Diarrhoea,6,16915031
6,22.1,Weight decreased,6,16915031
7,22.1,Fatigue,6,16915031
8,22.1,Muscular weakness,6,16915031
0,22.1,Tumour pain,3,16915043
1,22.1,Alopecia,3,16915043
0,22.1,Device use error,6,16915055
0,22.1,Metastases to lymph nodes,,16915059
1,22.1,Hormone-refractory prostate cancer,,16915059
2,22.1,Metastases to liver,,16915059
0,22.1,Metastases to liver,,16915064
0,22.1,Death,5,16915068
0,22.1,Hormone-refractory prostate cancer,,16915073
1,22.1,Metastases to liver,6,16915073
0,22.1,Large intestinal ulcer perforation,2,16915078
1,22.1,Cytomegalovirus enteritis,2,16915078
2,22.1,Megacolon,2,16915078
3,22.1,Opportunistic infection,5,16915078
0,22.1,Ileus,6,16915079
0,22.1,Malignant neoplasm progression,6,16915080
0,22.1,Malignant neoplasm progression,5,16915081
1,22.1,Device fastener issue,6,16915081
0,22.1,Anaphylactoid reaction,1,16915089
1,22.1,Urticaria,1,16915089
2,22.1,Lip swelling,1,16915089
0,22.1,Tubulointerstitial nephritis,6,16915095
0,22.1,Product use in unapproved indication,6,16915112
1,22.1,Blood creatinine increased,3,16915112
0,22.1,Hospice care,,16915113
0,22.1,Vitiligo,3,16915193
1,22.1,Malignant neoplasm progression,3,16915193
0,22.1,Interstitial lung disease,2,16915206
1,22.1,Herpes zoster,2,16915206
2,22.1,Cardiac failure congestive,2,16915206
3,22.1,Pneumonia,2,16915206
4,22.1,Malignant neoplasm progression,5,16915206
0,22.1,Malignant neoplasm progression,6,16915207
